MedTrace Logo

Quercetin Phytosome® Chronic Fatigue Symptoms

NCT05730660 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-08-06

No results posted yet for this study

Summary

The purpose of this study is to evaluate whether a 3-month period of quercetin supplementation (500 mg of Quercetin Phytosome®) is useful in the treatment of chronic fatigue, as assessed by the Fatigue Impact Scale (FIS-40). Secondary end points are sleep assessment through Pittsburgh Sleep Quality Index (PSQI) and muscle performance assessment through the Short Physical Performance Battery (SPPB) and body composition assessment using DXA.

Conditions

  • Chronic Fatigue Symptoms
  • Sleep
  • Physical Performance
  • Body Composition

Interventions

DIETARY_SUPPLEMENT

Quercetin group

2 capsules a day of Quercetin Fitosoma® of 250 mg each

DIETARY_SUPPLEMENT

Placebo group

2 tablets per day, white film-coated having the same appearance as Quercetin Fitosoma ® tablets.

Sponsors & Collaborators

  • Azienda di Servizi alla Persona di Pavia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2022-12-31
Completion
2023-01-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05730660 on ClinicalTrials.gov